<DOC>
	<DOCNO>NCT01039506</DOCNO>
	<brief_summary>The purpose study examine correlation UGT1A1 genotypes efficacy CPT-11 base regimen ( FOLFIRI , CPT-11+S-1 , CPT-11 ) patient metastatic colorectal cancer .</brief_summary>
	<brief_title>An Observational Study CPT-11 Based Regimens UGT1A1 Genotypes mCRC</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Metastatic colorectal cancer ( adenocarcinoma ) UGT1A1 genotyped patient Patients receive FOLFIRI , CPT11+S1 CPT11 alone therapy ( without molecular target agent ) Contraindication CPT11 ECOG PS 34 Patients receive CPT11 adjuvant chemotherapy History pelvic irradiation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>UGT1A1 , irinotecan</keyword>
</DOC>